RT @ultimovacs: Read about the randomized Ph2 FOCUS trial in head and neck cancer, expected readout H2 2024: https://t.co/VMYGnXp2Wm #canc…
89 followers
12,123 followers
RT @FrontOncology: New research: Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positiv…
6,543 followers
New research: Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS… https://t.co
651 followers
RT @ultimovacs: Read about the randomized Ph2 FOCUS trial in head and neck cancer, expected readout H2 2024: https://t.co/VMYGnXp2Wm #canc…